Iovance Biotherapeutics, Inc. seeks a Commercial Lead, Australia to establish and scale the Australian market for AMTAGVI and Proleukin.
You will own the commercial strategy, drive revenue and profitability, and lead the full sales cycle from market development to patient infusion. You will build executive relationships with treatment centres and authorities, ensure regulatory and quality standards, and coordinate cross-functionally to accelerate market access.
#J-18808-Ljbffr
Australia Commercial Lead: TIL Therapy Launch in Sydney employer: Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. is at the forefront of cancer treatment innovation, focusing on tumour-infiltrating lymphocyte (TIL) therapy. The company offers a dynamic work environment with opportunities for professional growth, particularly as it prepares to launch its first product in Australia. Employees can expect to be part of a pioneering team dedicated to transforming cancer care.
Contact Details:
Iovance Biotherapeutics, Inc. Recruitment Team
